Parallel Sessions

Wednesday 28 June 2023 15:30-17:00 CEST Auditorium

Hot Debates in Glaucoma Surgery

Chair(s): Shan Lin (United States); Stefano Gandolfi (Italy); Tanuj Dada (India);

Trabecular bypass - Cutting is better than Stenting
Paul Harasymowycz (Canada)
Trabecular bypass - Stenting is better than cutting
Shamira Perera (Singapore)
Failed Filtration Surgery - Do a Tube
Mary Qiu (United States)
Failed Filtration Surgery - Revise or Redo
Esther Hoffman (Germany)
Subconjunctival drainage implants - Ab interno is the preferred approach
Kaweh Mansouri (Switzerland)
Subconjunctival drainage implants - Ab Externo is better than Ab interno
Sameh Mosaed (United States)
Adding MIGS to Phaco is an effective IOP lowering strategy - Pro
Leon Au (United Kingdom)
Adding MIGS to Phaco is the most effective IOP lowering strategy â Con
Kuldev Singh (United States)
I still prefer Non Penetrating Deep Sclerectomy to Trabeculectomy
Tarek Shaarawy (Switzerland)
Non Penetrating Deep Sclerectomy is no match for Trabeculectomy
Norbert Pfeiffer (Germany)
Cyclophotocoagulation : Limited Continuous wave is much better than 360 degrees Micropulse
Sasan Moghimi (United States)
Cyclophotocoagulation: Go for 360 degrees Micropulse
Ziad Khoueir (Lebanon)

Wednesday 28 June 2023 15:30-17:00 CEST Room A

Angle Closure

Chair(s): David Friedman (United States); Mingguang He (Australia); Winnie Nolan (United Kingdom);

What do we know about the risk for visual impairment due to primary angle closure?
Lisandro Massanori Sakata (Brazil)
Angle Closure Disease: Genetics and Family History
Tin Aung (Singapore)
Is gonioscopy still essential for proper angle closure management?
Tony Hommer (Austria)
Acute Angle Closure: Best treatment approach in difficult cases
Michael Waisbourd (Israel)
How to properly incorporate recent RCT findings into daily clinical practice?
Augusto Azuara-Blanco (Ireland)
Frequently asked questions in PACD treatment strategies
Clement Tham (Hong Kong)
New technologies to improve risk assessment for angle closure disease
Benjamin Xu (United States)

Wednesday 28 June 2023 15:30-17:00 CEST Room B

Glaucoma and the Ocular Surface

Chair(s): Christophe Baudouin (France); Miriam Kolko (Denmark);

Effects of preservatives on goblet cells and meibomian glands
Anne Hedengran Nagstrup (Denmark)
The physical and chemical properties of antiglaucomatous eye drops
Andrew Tatham (United Kingdom)
Assessing the ocular surface: who needs to be preservative free?
Christophe Baudouin (France)
Managing the ocular surface before and after glaucoma surgery
Michele Figus (Italy)
PAP syndrome
Makoto Aihara (Japan)

Thursday 29 June 2023 10:30-12:00 CEST Auditorium

When in Rome...Do as the Experts do (Video-assisted skills transfer)

Chair(s): Vital Costa (Brazil); SK Fang (Malaysia); Francesco Oddone (Italy);

Trabeculectomy with releasable / adjustable sutures
Lingam Vijaya (India)
Phaco/SICS combined with Trabeculectomy
Surinder S Pandav (India)
Non Penetrating Deep Sclerectomy
Andre Mermoud (Switzerland)
Valved and non-valved glaucoma drainage devices
Joseph Anthony Tumbocon (Philippines)
Implants in the Schlemm's canal
Cedric Schweitzer (France)
Canaloplasty - Ab interno and Ab Externo
Norbert Koerber (Germany)
Ab interno trabeculotomy / goniectomy
Zeynep Aktas (Turkey)
Phaco in PXF with small pupils and zonular deficiency
Arsham Sheybani (United States)
Subconjunctival drainage implants
Antonio Fea (Italy)
Needling for a failing / failed filter
Visanee Tantisevi (Thailand)

Thursday 29 June 2023 10:30-12:00 CEST Room A

AI for Eyes

Chair(s): Felipe Medeiros (United States); Leopold Schmetterer (Singapore); Xiulan Zhang (China);

AI for all eyes: is glaucoma screening now feasible?
Ching-Yu Cheng (Singapore)
AI for all eyes: with angle closure
Fei Li (China)
Structure and Function: Can AI optimize Visual Function assessment from Imaging data?
Carol Cheung (Hong Kong)
Glaucoma Progression Assessment: Can we make it better?
Felipe Medeiros (United States)
Incorporating clinical and genetic data to predict glaucoma outcomes
Siamak Yousefi (United States)
Big Thinking with Big Data
Anja Tuulonen (Finland)

Thursday 29 June 2023 10:30-12:00 CEST Room B

Glaucoma treatment beyond IOP

Chair(s): Robert Casson (Australia); Jonathan Crowston (Singapore);

Is exercise the exit of glaucoma?
Vicki Chrysostomou (Australia)
NAM and the preclinical evidence Is NAM the hit? Or Is NAM the hit?
Jonathan Crowston (Singapore)
Novel pharmacologic targets
Derek Welsbie (United States)
Metabolic Syndrome and Glaucoma
Gavin Roddy (United States)
Bioenergetic Neuroprotection in Glaucoma
Robert Casson (Australia)
MÃ¼ller glia, the natural neuroprotectant
Elena Vecino (Spain)

Thursday 29 June 2023 13:30-15:00 CEST Room A

Aqueous humor dynamics and IOP

Chair(s): Megumi Honjo (Japan); Michael S. Kook (South Korea); Arthur Sit (United States);

What do we know about the genetics and IOP?
Anthony Khawaja (United Kingdom)
How does the eye regulate IOP?
Michael Fautsch (United States)
What causes IOP variations
Arthur Sit (United States)
Distal outflow and EVP
Alex Huang (United States)
Surgery and aqueous humor dynamics
Sheng Lim (United Kingdom)
Continuous monitoring of IOP: Ready for prime time?
Kaweh Mansouri (Switzerland)

Thursday 29 June 2023 13:30-15:00 CEST Auditorium

Clinical Debates

Chair(s): Min Hee Suh (South Korea); Fabian Lerner (Argentina); Robert Weinreb (United States);

Exercises, Diet, Nicotinamide, Meditation helps Glaucoma control - YES
Jonathan Crowston (Singapore)
Exercises, Diet, Nicotinamide, Meditation helps Glaucoma control - NO
Paul Kaufman (United States)
Stand-alone Trabecular MIGS: should we always consider SLT first? YES
Luciano Quaranta (Italy)
Stand-alone Trabecular MIGS: should we always consider SLT first? NO
Julian Garcia Feijo (Spain)
IOP measurements are essential for proper glaucoma follow-up - YES
Jamie Brandt (United States)
IOP measurements are essential for proper glaucoma follow-up - NO
Gustavo de Moraes (United States)
OCT angiography is useful for glaucoma diagnosis and follow-up - YES
Harsha Rao (India)
OCT angiography is useful for glaucoma diagnosis and follow-up - NO
Tae-Woo Kim (South Korea)
NTG - Is IOP ever too low to operate? YES
Ki Ho Park (South Korea)
NTG - Is IOP ever too low to operate? NO
Makoto Aihara (Japan)
Knowing a patient's genotype is as important as knowing their IOP? YES
Janey Wiggs (United States)
Knowing a patient's genotype is as important as knowing their IOP? NO
Kuldev Singh (United States)

Thursday 29 June 2023 13:30-15:00 CEST Room B

All Roads Lead to Glaucoma (Early Pathology in Glaucoma and its Detection)

Chair(s): Neeru Gupta (Canada); Leonard Levin (Canada); Toru Nakazawa (Japan);

Bloodflow and auto regulation
Ingrida Januleviciene (Lithuania)
Past, now and future thought of glaucoma pathology
Leonard Levin (Canada)
What about the lamina cribrosa?
Deepak Edward (United States)
Can we rescue RGCs before irreversible cell death occurs?
Yvonne Ou (United States)
Neuroprotection a shattered dream or not?
Toru Nakazawa (Japan)
What is the role of astrocytes and microglia in glaucoma?
Qi Cui (United States)

Thursday 29 June 2023 13:30-15:00 CEST Room G

Africa Symposium

Chair(s): Neeru Gupta (Canada); Sola Olawoye (Nigeria);

New developments in the Genetics of OAG in SSA
Susan Williams (South Africa)
Surgery, not medicine, should be the standard firstline treatment for open-angle glaucoma in SSA
Naa Tagoe (Ghana)
Glaucoma drainage devices in the management of OAG Experience and outcomes in SSA.
Sheila Marco (Kenya)
Major collaborative glaucoma studies in SSA â ongoing and completed: Findings so far?
Sola Olawoye (Nigeria)
Is SLT relevant in the management of POAG in Africa?
TBA
Improving glaucoma management across SSAHow has training health workers, awareness, diagnosis and management improved over the past 10 years?
Nkiru Akaraiwe (Nigeria)

Friday 30 June 2023 10:30-12:00 CEST Auditorium

Dante's Inferno: How to Save the Day? (Surgical Nightmares)

Chair(s): Fabian Lerner (Argentina); Shlomo Melamed (Israel); Sola Olawoye (Nigeria);

Persistent hypotony post trabeculectomy
Wilma Lelis Barboza (Brazil)
Persistent hypotony post tubes
Remo Susanna Jr. (Brazil)
Bleb related infection and post infection bleb repair
Dexter Leung (Hong Kong)
Malignant glaucoma post filtration
Mohammad Pakravan (Iran)
Choroidal effusion in nanophthalmos
Sharmila Baburajendran (India)
Cyclodialysis cleft
Arsham Sheybani (United States)
Implant/device exposure
Maria Fernanda Delgado (Colombia)
Suprachoroidal Hemorrhage
Michael Coote (Australia)

Friday 30 June 2023 10:30-12:00 CEST Room A

Glaucoma Progression

Chair(s): Xinghuai Sun (China); David Garway-Heath (United Kingdom); Gabor Hollo (Hungary);

Combining structure and structure?
Gustavo de Moraes (United States)
Do we need to incorporate OCT angiography data?
Chris Leung (Hong Kong)
Difficulties for detecting progression with OCT in the real world
Paul Healey (Australia)
Optimizing VF progression detection
Kouros Nouri-Mahdavi (United States)
How not to miss progression in advanced disease
Lucy Shen (United States)
How much change is clinically significant? And what defines a Fast-Progressor?
Linda Zangwill (United States)
Genetics in Glaucoma Progression
Janey Wiggs (United States)

Friday 30 June 2023 10:30-12:00 CEST Room B

Risk Factors Debate

Chair(s): Arthur Sit (United States); Thasarat Vajaranant (United States); Ningli Wang (China);

Diabetes IS a Risk Factor
Steven S. Mansberger (United States)
Diabetes is NOT a risk factor
Sasan Moghimi (United States)
Myopia IS a risk factor
Ching-Yu Cheng (Singapore)
Myopia is NOT a risk factor
Parul Ichhpujani (India)
Central Corneal Thickness IS a risk factor
Jamie Brandt (United States)
Central Corneal Thickness IS NOT a risk factor
Anthony Khawaja (United Kingdom)

Friday 30 June 2023 13:30-15:00 CEST Auditorium

Decision-making in Glaucoma Surgery

Chair(s): Eytan Blumenthal (Israel); Ingeborg Stalmans (Belgium); Lingam Vijaya (India);

How to make a decision to operate?
Franz Grehn (Germany)
Type of anesthesia and changes in anticoagulation therapy
Tom Eke (United Kingdom)
Which MIGS to choose for which patient?
Ike Ahmed (Canada)
MIGS has failed, what next?
Sheng Lim (United Kingdom)
Tube has failed, what next?
Stefano Gandolfi (Italy)
Should I combine two MIGS procedures?
Inder Paul Singh (United States)
Why operate , just use Lasers (SLT/ Micropulse)
Gus Gazzard (United Kingdom)
Should we use MIGS for Primary Angle Closure Glaucoma?
Xiulan Zhang (China)

Friday 30 June 2023 13:30-15:00 CEST Room A

Imaging in Glaucoma: from Basics to Advanced

Chair(s): Jeffrey Liebmann (United States); Hams Lemij (Netherlands); Linda Zangwill (United States);

Outflow Pathway Abnormalities - are we able to evaluate and improve outflow?
Alex Huang (United States)
The structure-function relationship in glaucoma
Roberto Vessani (Brazil)
OCT imaging artifacts and abnormalities due to non-glaucomatous diseases
Ryo Asaoka (Japan)
Imaging in High Myopia: Tips for Daily Clinical Practice
Jost Jonas (Germany)
Anterior segment OCT and Angle Closure Glaucoma
Monisha Nongpiur (Singapore)
Deep optic nerve head microvasculature assessment using OCT angiography
Min Hee Suh (South Korea)
New structural parameters
Harsha Rao (India)
Next generation imaging
Alessandro Jammal (United States)

Friday 30 June 2023 13:30-15:00 CEST Room B

Personalized Medicine (incl. multiomics)

Chair(s): Irene Copati (Argentina); Carlo Traverso (Italy); George Cioffi (United States);

Testing - when to do more, and when to do less
David Garway-Heath (United Kingdom)
Artificial intelligence to personalize care
Felipe Medeiros (United States)
Better target IOP setting through forecasting
TBA
Personalized guidance regarding lifestyle choices
Louis Pasquale (United States)
Personalizing detection and treatment
Janey Wiggs (United States)
Identifying subsets of patients needing aggressive treatment
Kouros Nouri-Mahdavi (United States)

Friday 30 June 2023 13:30-15:00 CEST Room C

Associate Advisory Board Symposium

Chair(s): Benjamin Xu (United States); Ziad Khoueir (Lebanon); Luis Abegao Pinto (Portugal);

Update on Optic Nerve Regeneration
Jiun Do (United States)
Update on New Glaucoma Implants
Chelvin Sng (Singapore)
What about fast progressing NTG
Miriam Kolko (Denmark)
Subconjunctival MIGS
Luis Abegao Pinto (Portugal)
Trabecular Ablation MIGS
Ziad Khoueir (Lebanon)
Ciliary Body Ablation and Glaucoma
Aaki Shukla (United States)

Saturday 01 July 2023 08:30-10:00 CEST Auditorium

How to (re)organize Glaucoma Treatment Strategies?

Chair(s): Andrew Tatham (United Kingdom); Lisandro Massanori Sakata (Brazil); Omnia Hamam (United Arab Emirates);

Trabecular MIGS Pro-active treatment evidences: who (really) needs it?
Jella An (United States)
Too much of a good thing: are we over-treating?
TBA
Are laser treatments our best shot? Efficacy, how to monitor it and when to go for re-treatment
Gus Gazzard (United Kingdom)
Topical Glaucoma Treatment: the good and the bad
Miriam Kolko (Denmark)
Sustained drug delivery systems: do they make a difference?
Philiph Phatudi (South Africa)
First step is the best step - what's the best first line option for OHT, early glaucoma, advanced glaucomaÂ
Steven S. Mansberger (United States)
What are the current recommended treatment options for progressing advanced glaucoma?
Florent Aptel (France)
Glaucoma treatment armamentarium: What remains to be investigated in future trials?
Robert Weinreb (United States)

Saturday 01 July 2023 11:45-13:15 CEST Room A

How can I convince...?

Chair(s): Pradeep Ramulu (United States); Remo Susanna Jr. (Brazil); Kaweh Mansouri (Switzerland);

Take their eyedrops (Doctor)
Julia Rosdahl (United States)
Take their eyedrops (Patient)
Michael Chaglasian (United States)
Get an SLT as primary therapy (Doctor)
Tony Realini (United States)
Get an SLT as primary therapy (Patient)
Catherine Birt (Canada)
Get a sustained release therapy (Doctor)
Ahmad Aref (United States)
Get a sustained release therapy (Patient)
Doug Rhee (United States)
Get a clear lens extraction for PAC (Doctor)
Augusto Azuara-Blanco (Ireland)
Get a clear lens extraction for PAC (Patient)
Ramanjit Sihota (India)
Get a trabeculectomy (Doctor)
Catherine Green (Australia)
Get a trabeculectomy (Patient)
Hari Jayaram (United Kingdom)

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

WGC-2025 WILL START IN